about
A dual infection pseudorabies virus conditional reporter approach to identify projections to collateralized neurons in complex neural circuitsHerpesvirus replication compartments originate with single incoming viral genomes.Human papillomavirus tumor infection in esophageal squamous cell carcinoma.Evolution and Management of Treatment-Related Toxicity in Anal Cancer.Total neoadjuvant therapy for rectal cancer: An emerging option.Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality.Radiosensitive orbital metastasis as presentation of occult colonic adenocarcinomaCombination Intensity Modulated Proton Therapy and Passive Scatter Boost for Rapidly Progressing Nasal Cavity Squamous Cell Carcinoma.The physician as dictator.Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma.Radiotherapy Advances in Pediatric Neuro-OncologyCoincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanismsFavorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphomaRole of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy EraOmitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapyPrimary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure<sup/>Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big DataMixed Adenoneuroendocrine Carcinoma, Amphicrine Type, of the Small BowelHighlighting the need for reliable clinical trials in glioblastomaDisease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic ReviewSkeletal muscle metastasis from signet ring cell esophageal adenocarcinomaOutcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancerPatterns of failure following proton beam therapy for head and neck rhabdomyosarcomaDefinitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignanciesReporting and exclusion of sexual and gender minorities in cancer clinical trialsEmerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid TissueIncidence and correlates of HIV exclusion criteria in cancer clinical trialsIncreased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapyExclusion of Men from Randomized Phase III Breast Cancer Clinical TrialsSex-Based Disparities Among Cancer Clinical Trial ParticipantsAssembling the brain trust: the multidisciplinary imperative in neuro-oncologyFactors Associated With Age Disparities Among Cancer Clinical Trial ParticipantsPatterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcomaThe Trials (and Tribulations) of Complementary and Alternative Medicine in OncologyAssessing the Impact of Complementary and Alternative Medicine Trials in OncologyDisparities along the glioblastoma clinical trials landscapeReducing Firearm Injuries and Deaths in the United States
P50
Q21091026-865C1E05-D77E-425A-9137-D0CA272C898BQ35714830-0116C703-A701-45FA-9043-76224AFA81A9Q38510254-0A231F60-87EA-42FD-9CD1-CB2EE5470377Q38790536-FA52E35A-7544-49EA-9D85-A3DA3DF514D9Q39179402-F61D8882-8B9C-4A69-B683-C30999B45EE8Q40581391-9B703ED6-2D7A-4C74-AB94-5B1126B9AFF4Q42079792-603EE788-6FBD-48F6-8DB1-3596466112BCQ46911247-1E0C5D49-BFCE-46C7-86C8-F9E39D046A72Q50121186-C96E33CC-B296-43AE-9F2A-6BF7963FFD52Q52687094-DC1B4A88-5C91-49E5-AAC9-A7D3DA57E566Q58612655-2D40FFC6-5FA7-40D8-B0C1-51FCC681349CQ60045780-96987856-B0C6-4855-8C0A-67EB848AB7B7Q64080770-184BBBEB-413A-4237-AD88-2B85C2157B84Q86512733-7DF9D799-888C-422A-B86C-3406B0F35953Q88262639-BB58A186-B034-4255-8354-8C613DBC8C29Q88479410-789DC9EE-44B3-4BCA-8FB2-3ED55B68BCACQ89264492-8A086E37-A8D4-45ED-B614-27FB2CA2FF90Q89318186-804B8CFC-66CB-4100-9362-D78C602B0C40Q89420712-9AF0C06B-C4BC-4C9C-9E1C-0F29A8BF67DCQ89844688-D9EBC39E-0E9D-47E6-8D5F-BAEA0991D6D1Q89953535-092AAD36-637A-43EE-89A2-A6CA290AA0E6Q90027402-AFF89F10-5308-463C-A66B-38C60780CAB4Q90037242-1A4F76C0-DC5B-474A-83F4-4517D003B75CQ90089413-10197CF6-3E74-4AE5-BA35-D83E94570D82Q90478038-3463C680-FB87-4E42-A032-FD27A406F76EQ91241768-34607726-DCF5-44CA-BF77-2EDD98606182Q91351524-233E39E2-9AE3-4BD9-94F8-A4C5B2BB8725Q91502720-40CFA4B9-81FB-44E6-B2F9-86C991C6FF0BQ91775298-73440630-3C4A-4A25-86C3-908872AE9A6BQ92215703-4EFFB875-0C9C-4DA1-83FA-29BFC8461C65Q92437821-BCC3779B-005C-4D53-A872-5F3072EDB94AQ92488527-2C9EF285-C3CC-4B2A-9868-6C05A7D04F14Q92516645-E39E2A0C-0D42-4C30-BD50-D17A5E63DB35Q92528456-EC79F685-521A-4E75-BC55-08E26A099527Q92909917-AE0FBBE8-AE17-4AB6-9C52-01B4CB6E6836Q93371521-E5697428-30EA-454C-A4D3-FBA97A147D38Q95514446-5A6FFF52-A0A2-4AC0-8007-9652114F752A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ethan B Ludmir
@ast
Ethan B Ludmir
@en
Ethan B Ludmir
@es
Ethan B Ludmir
@nl
Ethan B Ludmir
@sl
type
label
Ethan B Ludmir
@ast
Ethan B Ludmir
@en
Ethan B Ludmir
@es
Ethan B Ludmir
@nl
Ethan B Ludmir
@sl
prefLabel
Ethan B Ludmir
@ast
Ethan B Ludmir
@en
Ethan B Ludmir
@es
Ethan B Ludmir
@nl
Ethan B Ludmir
@sl
P106
P31
P496
0000-0002-5472-5344